0

Shares

Glycogen Synthase Kinase 3 Beta Inhibitors Therapeutics – Pipeline Analysis

Shared by Manish Kumar | 0 0 0 | about 21 days ago

Glycogen synthase kinase 3 beta (GSK-3) is an attractive target for the treatment of psychiatric disorders and neurodegenerative diseases. Many GSK-3 inhibitors have been developed for the treatment of different central nervous system disorders.

Read More On www.pharmaproff.com

Categories Clinical research Healthcare

Links

https://www.pharmaproff.com/report/glycogen-synthase-kinase-3-beta-inhibitors
http://bit.ly/2ROScSd
http://bit.ly/2RSFdz8

0 Votes

You must log in to post a comment

0 Comments